Author:
Nasr Mohammed Y.,Alhuqayl Talal A.,Alshammari Hassan A.,Alkhudhayri Hamad H.,Alzin Majed B.,Sulimani Riad A.
Abstract
Polycystic ovarian syndrome (PCOS) is an important public health problem. In addition to its gynecologic and hyperandrogenic manifestations, it has been associated with an increased incidence of prediabetic state, gestational diabetes mellitus (GDM), and diabetes mellitus. The pathogenesis of PCOS, as well as its metabolic consequences, is complex. The two main causative factors are intrinsic insulin resistance and impaired β cell function. Obesity has frequently been reported in PCOS; however, it is not entirely responsible for the insulin resistance in this population. PCOS should be managed with lifestyle modifications and appropriate dietary measures. In addition, treatment with insulin sensitizers is usually needed. PCOS provides a unique opportunity for the screening and early diagnosis of diabetes and its management.
Reference109 articles.
1. Polycystic ovarian syndrome in adolescents;Creatsas;Curr Opin Obstet Gynecol,2007
2. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria;Yildiz;Hum Reprod,2012
3. Diagnosis of polycystic ovary syndrome;Trivax;Clin Obstet Gynecol,2007
4. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy;Patel;J Steroid Biochem Mol Biol,2018
5. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome – Part 1;Goodman;Endocr Pract,2015